Navigation Links
Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation
Date:12/8/2009

WASHINGTON, Dec. 8 /PRNewswire-USNewswire/ -- As part of its efforts to expand awareness of the importance of medical progress in the United States, the Pharmaceutical Research and Manufacturers of America (PhRMA) is announcing today the addition of seven new member companies.

PhRMA's Board of Directors recently voted to expand its membership to include an impressive list of progressive companies that represent some of the most innovative ideas and talent in America. With these new additions, PhRMA further bolsters its representation of a diverse group of biopharmaceutical research companies that all share the important mission of discovering and developing new medicines that can help patients win their battle against disease.

The seven new member companies will also be joining PhRMA in its support for comprehensive health care reform. America's pharmaceutical research and biotechnology companies have played a constructive role in helping ensure that a comprehensive health reform bill that is good for all Americans -- particularly one that supports medical innovation and improves patient care -- gets to President Obama's desk in the near future.

The new PhRMA members are Cubist Pharmaceuticals, Inc., Lexington, MA; OSI Pharmaceuticals, Inc., Melville, NY; Alexion Pharmaceuticals, Inc., Cheshire, CT; Ferring Pharmaceuticals, Inc., Parsippany, NJ; Talecris Biotherapeutics, Inc., Raleigh, NC; Vifor Pharma, Basking Ridge, NJ; and Xoma Ltd, Berkeley, CA. To learn more about these companies, go to www.phrma.org.

In addition to developing cutting-edge medicines that help advance patient care in the U.S. and abroad, the new members -- which have a presence in six different states -- have contributed to America's economy by supporting thousands of jobs.

Today, America continues to lead the world in the discovery and development of new m
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
2. Seven-Year Neck Pain Study Sheds Light on Best Care
3. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
4. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
5. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
11. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
(Date:6/29/2015)... ... June 29, 2015 , ... ... independent auditor of customer service for the 40-center nursing home group. Sixteen of ... nursing centers in the United States in one or more customer service areas. ...
(Date:6/29/2015)... ... ... With Urgent Care Medicine now serving a vital role in our health care ... and the Medical Society of Delaware to provide its latest professional development resource that ... , According to Matthew Bader, Exam Master CEO and President, “This resource is the ...
(Date:6/29/2015)... ... ... OR Manager announced Monday the launch of an enhanced http://www.ormanager.com . ... logo and weekly eLetter. The website contains the same informational articles, products, and resources ... , In addition to a refreshed look, http://www.ormanager.com now provides users ...
(Date:6/29/2015)... ... June 29, 2015 , ... The Food Safety and ... The Hong Kong Polytechnic University (PolyU) has developed a new method for rapid ... has been a long-term issue in food safety, and becomes particularly important with ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... and behavior, is a popular focus for corporate training seminars. As many as ... practices, improve training, foster teamwork, and increase productivity. , With the demand ...
Breaking Medicine News(10 mins):Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2
... LES ULIS, France, September 19 Following the,successful ... made it,possible to raise EUR7.6 million, Quantel signed ... company Wavelight AG to acquire,WaveLight Aesthetic GmbH, its ... agreement The acquisition price includes a EUR4.6 ...
... Sept. 19 If you,ve been experiencing watery,eyes and ... the,rise in the U.S., with an estimated 50 million ... to the tune of 3 billion,dollars a year, often ... say in-vitro blood tests, the latest generation of,allergy tests, ...
... with mice might lead to treatments for diseases such as ... U.S. researchers say they,ve successfully reprogrammed adult stem cells from ... cell types, including functional blood vessels, contractile cardiac tissue, and ... adult testes stem cells from humans, they may offer a ...
... Easily accessed and plentiful, adult stem cells found in a ... wide range of tissue types to help him fight disease ... cells. , That,s the promise of a breakthrough study in ... in New York City, who report their findings in the ...
... Americans will,have access to high-quality, evidence-based care for ... U.S. Senate. The,"Mental Health Parity Act of 2007" ... to provide parity with respect to all financial,requirements ... ) "AHIP applauds the Senate for ...
... Sept. 19 When Michael Murphy of,Seymour, Iowa, was ... the halftime of the September 15th Iowa vs. Iowa ... "Join the Ride, Iowa",raffle. The Iowa Farm Bureau donated ... and raffle (tickets were $10 each) to the American,Lung ...
Cached Medicine News:Health News:QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH 2Health News:Stem Cells From Testes Produce Wide Range of Tissue Types 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 3Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 4Health News:Renewable Fuel Chopper Raffle Nets $113,000 for American Lung Association Clean Air Choice Program 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: